Important Update – Belviq

Attention to any patient taking Belviq (Lorcaserin) for weight loss. The FDA has requested withdrawal of this medication due to cancer risk.

Follow link below, and discontinue use of this medication. Contact your health care provider for more information.

https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market

Share
Back to Top